HBIO stock forecast
Our latest prediction for Harvard Bioscience, Inc.'s stock price was made on the May 7, 2020 when the stock price was at 2.53$.
In the short term (2weeks), HBIO's stock price should outperform the market by 3.55%. During that period the price should oscillate between -7.59% and +13.17%.
In the medium term (3months), HBIO's stock price should underperform the market by -0.48%. During that period the price should oscillate between -24.31% and +32.64%.Get email alerts
Create a solid portfolio with HBIO
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
At the moment the company generates 116M USD in revenues.
On its last earning announcement, the company reported a loss of -0.12$ per share.
The book value per share is 2.11$
Three months stock forecastMay 7, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|